Related Experiment Videos
No false start for novel pseudotyped vectors
1Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA. retrovir@bragg.bio.purdue.edu
Current Opinion in Biotechnology
|December 3, 2002
Summary
Novel pseudotyped vectors, particularly those using alphavirus glycoproteins, offer promising new tools for gene transfer and studying viral entry. Their expanding diversity enhances opportunities for targeted gene delivery into specific cells.
Area of Science:
- Virology
- Molecular Biology
- Gene Therapy
Background:
- Pseudotyped vectors are engineered viral particles used for gene delivery and studying viral entry mechanisms.
- Recent advancements have led to the development of novel pseudotyped retroviruses and lentiviruses.
- Alphavirus glycoproteins are emerging as particularly promising components for pseudotyping virus vectors.
Purpose of the Study:
- To highlight the utility of pseudotyped vectors in gene transfer and viral entry studies.
- To discuss the recent construction of novel pseudotyped retroviruses and lentiviruses.
- To emphasize the potential of alphavirus glycoprotein-pseudotyped vectors.
Main Methods:
- Construction and characterization of novel pseudotyped retroviral and lentiviral vectors.
- Incorporation of alphavirus glycoproteins into virus vector envelopes.
- Evaluation of gene transfer efficiency and tropism of pseudotyped vectors.
Main Results:
- Several novel pseudotyped retroviruses and lentiviruses have been successfully constructed.
- Alphavirus glycoprotein-pseudotyped vectors demonstrate significant potential for gene transfer applications.
- The growing diversity of pseudotyped vectors expands options for cell-specific gene delivery.
Conclusions:
- Pseudotyped vectors are valuable tools for both gene therapy and virology research.
- Alphavirus glycoprotein-based vectors represent a promising advancement in vector technology.
- The expanding repertoire of pseudotyped vectors facilitates targeted gene transfer to specific cell types.